Picture of Taisho Pharmaceutical Holdings Co logo

4581 — Taisho Pharmaceutical Holdings Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Taisho Pharmaceutical HD -2022/23 parent results

May 11 (Reuters)- 
          Taisho Pharmaceutical Holdings Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to     NEXT     
                Mar 31, 2023    Mar 31, 2022   Mar 31, 2024     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             8.21            10.03                                
                 (-18.2 pct)    (+138.9 pct)                             
  Operating         6.63             8.36                                
                 (-20.7 pct)    (+235.7 pct)                             
  Recurring         6.56             8.26                                
                 (-20.6 pct)    (+235.0 pct)                             
  Net               6.01            10.69                                
                 (-43.8 pct)    (+472.1 pct)                             
  EPS             73.26 yen      131.16 yen                              
  EPS Diluted     73.17 yen      131.01 yen                              
  Ann Div        100.00 yen      100.00 yen     100.00 yen               
  -Q2 Div         50.00 yen       50.00 yen      50.00 yen               
  -Q4 Div         50.00 yen       50.00 yen      50.00 yen               
  
  NOTE - Taisho Pharmaceutical Holdings Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T

Recent news on Taisho Pharmaceutical Holdings Co

See all news